SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-012995
Filing Date
2024-01-23
Accepted
2024-01-23 16:16:12
Documents
7
Effectiveness Date
2024-01-23

Document Format Files

Seq Description Document Type Size
1 S-8 d735625ds8.htm S-8 51521
2 EX-4.3 d735625dex43.htm EX-4.3 27488
3 EX-5.1 d735625dex51.htm EX-5.1 62488
4 EX-23.2 d735625dex232.htm EX-23.2 2314
5 EX-FILING FEES d735625dexfilingfees.htm EX-FILING FEES 17706
6 GRAPHIC g735625dsp17.jpg GRAPHIC 3130
7 GRAPHIC g735625dsp18.jpg GRAPHIC 2355
  Complete submission text file 0001193125-24-012995.txt   170524
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo BioPharma Group plc (Filer) CIK: 0001719714 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-276656 | Film No.: 24552848
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)